Literature DB >> 8892907

Cytopathogenicity of a pestivirus correlates with a 27-nucleotide insertion.

N Tautz1, G Meyers, R Stark, E J Dubovi, H J Thiel.   

Abstract

Cytopathogenic (cp) bovine viral diarrhea virus (BVDV) strains are generated in cattle persistently infected with noncytopathogenic (noncp) BVDV.cp BVDV strains are considered crucial for the development of fatal mucosal disease. Comparative analysis of cp and noncp BVDV strains isolated from one animal suffering from mucosal disease revealed that the genomes of the cp BVDV strain (CP7) and the corresponding noncp BVDV strain (NCP7) are highly homologous. However, only the genome of CP7 contains an insertion of 27 nucleotides in the NS2 coding region. The inserted sequence represents a duplication of bases 4064 to 4090 of the viral genome, located between the formerly neighboring nucleotides 4353 and 4354. Parts of the viral polyproteins of CP7 and NCP7 were expressed in the T7 vaccinia virus system. These studies revealed that the insertion identified in the CP7 genome is necessary and sufficient for the induction of NS2-3 cleavage. Since the expression of NS3 is strictly correlated to cp BVDV, the insertion identified in the genome of BVDV CP7 represents most likely the relevant mutation leading to the evolvement of CP7 from NCP7.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8892907      PMCID: PMC190856     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Specific immune tolerance in an apparently healthy bull persistently infected with bovine viral diarrhea virus.

Authors:  M F Coria; A W McClurkin
Journal:  J Am Vet Med Assoc       Date:  1978-02-15       Impact factor: 1.936

2.  Bovine viral diarrhea virus genomic organization.

Authors:  M S Collett; M Wiskerchen; E Welniak; S K Belzer
Journal:  Arch Virol Suppl       Date:  1991

3.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

4.  Characterization of bovine viral diarrhea virus proteins.

Authors:  A F Purchio; R Larson; M S Collett
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

5.  Use of protein A-bearing staphylococci for the immunoprecipitation and isolation of antigens from cells.

Authors:  S W Kessler
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

6.  Processing in the pestivirus E2-NS2 region: identification of proteins p7 and E2p7.

Authors:  K Elbers; N Tautz; P Becher; D Stoll; T Rümenapf; H J Thiel
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

7.  Hepatitis C virus-encoded NS2-3 protease: cleavage-site mutagenesis and requirements for bimolecular cleavage.

Authors:  K E Reed; A Grakoui; C M Rice
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Comparison of the p125 coding region of bovine viral diarrhea viruses.

Authors:  C Pellerin; S Moir; J Lecomte; P Tijssen
Journal:  Vet Microbiol       Date:  1995-06       Impact factor: 3.293

10.  The NS2 protein of hepatitis C virus is a transmembrane polypeptide.

Authors:  E Santolini; L Pacini; C Fipaldini; G Migliaccio; N Monica
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

View more
  37 in total

Review 1.  Perspectives for the treatment of infections with Flaviviridae.

Authors:  P Leyssen; E De Clercq; J Neyts
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  A cellular J-domain protein modulates polyprotein processing and cytopathogenicity of a pestivirus.

Authors:  G Rinck; C Birghan; T Harada; G Meyers; H J Thiel; N Tautz
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

3.  CRISPR/Cas9-Mediated Knockout of DNAJC14 Verifies This Chaperone as a Pivotal Host Factor for RNA Replication of Pestiviruses.

Authors:  O Isken; A Postel; B Bruhn; E Lattwein; P Becher; N Tautz
Journal:  J Virol       Date:  2019-02-19       Impact factor: 5.103

4.  RNA structural elements determine frequency and sites of nonhomologous recombination in an animal plus-strand RNA virus.

Authors:  Sophia Austermann-Busch; Paul Becher
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

5.  Correlation between point mutations in NS2 and the viability and cytopathogenicity of Bovine viral diarrhea virus strain Oregon analyzed with an infectious cDNA clone.

Authors:  B M Kümmerer; G Meyers
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  Insertion of a sequence encoding light chain 3 of microtubule-associated proteins 1A and 1B in a pestivirus genome: connection with virus cytopathogenicity and induction of lethal disease in cattle.

Authors:  G Meyers; D Stoll; M Gunn
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

7.  Bovine viral diarrhea virus strain Oregon: a novel mechanism for processing of NS2-3 based on point mutations.

Authors:  B M Kümmerer; D Stoll; G Meyers
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

8.  Viral sequence insertions and a novel cellular insertion in the NS2 gene of cytopathic isolates of bovine viral diarrhea virus as potential cytopathogenicity markers.

Authors:  Adám Bálint; Vilmos Pálfi; Sándor Belák; Claudia Baule
Journal:  Virus Genes       Date:  2005-01       Impact factor: 2.332

9.  Cell-derived sequences in the N-terminal region of the polyprotein of a cytopathogenic pestivirus.

Authors:  A Müller; G Rinck; H-J Thiel; N Tautz
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Replication of a cytopathic strain of bovine viral diarrhea virus activates PERK and induces endoplasmic reticulum stress-mediated apoptosis of MDBK cells.

Authors:  Robert Jordan; Lijuan Wang; Thomas M Graczyk; Timothy M Block; Patrick R Romano
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.